The DWORF micropeptide enhances contractility and prevents heart failure in a mouse model of dilated cardiomyopathy

Catherine A. Makarewich, Amir Z. Munir, Gabriele G. Schiattarella, Svetlana Bezprozvannaya, Olga N. Raguimova, Ellen E. Cho, Alexander H. Vidal, Seth L. Robia, Rhonda S Bassel-Duby, Eric N Olson

Research output: Contribution to journalArticlepeer-review

82 Scopus citations

Abstract

Calcium (Ca2+ ) dysregulation is a hallmark of heart failure and is characterized by impaired Ca2+ sequestration into the sarcoplasmic reticulum (SR) by the SR-Ca2+-ATPase (SERCA). We recently discovered a micropeptide named DWORF (DWarf Open Reading Frame) that enhances SERCA activity by displacing phospholamban (PLN), a potent SERCA inhibitor. Here we show that DWORF has a higher apparent binding affinity for SERCA than PLN and that DWORF overexpression mitigates the contractile dysfunction associated with PLN overexpression, substantiating its role as a potent activator of SERCA. Additionally, using a well-characterized mouse model of dilated cardiomyopathy (DCM) due to genetic deletion of the muscle-specific LIM domain protein (MLP), we show that DWORF overexpression restores cardiac function and prevents the pathological remodeling and Ca2+ dysregulation classically exhibited by MLP knockout mice. Our results establish DWORF as a potent activator of SERCA within the heart and as an attractive candidate for a heart failure therapeutic.

Original languageEnglish (US)
Article numbere38319
JournaleLife
Volume7
DOIs
StatePublished - 2018

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology
  • General Immunology and Microbiology
  • General Neuroscience

Fingerprint

Dive into the research topics of 'The DWORF micropeptide enhances contractility and prevents heart failure in a mouse model of dilated cardiomyopathy'. Together they form a unique fingerprint.

Cite this